临床外科杂志 ›› 2023, Vol. 31 ›› Issue (12): 1160-1163.doi: 10.3969/j.issn.1005-6483.2023.12.014

• 论著 • 上一篇    下一篇

miR-539-5p、CAAP1在胃癌组织中的表达及临床意义

  

  1. 710054 西安市第九医院消化内科(黄小平、李萍)，血管介入科(李轶)
  • 收稿日期:2023-02-02 出版日期:2023-12-20 发布日期:2023-01-15
  • 通讯作者: 李萍，Email:vlqmtui593306@163.com
  • 基金资助:
    西安市第九医院科研项目(编号：2020-7)

Expression and clinical significance of miR-539-5p and Caspase activity and apoptosis inhibitory factor 1 in gastric cancer tissue

  1. Department of Gastroenterology,  Xi ’an Ninth Hospital, Shaanxi,Xi’an 710054, China
  • Received:2023-02-02 Online:2023-12-20 Published:2023-01-15

PDF (PC)

60

摘要： 目的 探讨微小RNA(miR)-539-5p、Caspase活性和凋亡抑制因子1(CAAP1)在胃癌组织中表达及其临床意义。方法 2018年1月～2019年12月我院接受手术治疗胃癌组织标本及对应的癌旁组织102例，检测癌组织miR-539-5p、CAAP1表达水平，探讨miR-539-5p、CAAP1表达与临床病理参数及预后的关系。Pearson法分析miR-539-5p与CAAP1表达相关性。Kaplan-Meier法分析胃癌病人生存期。采用Cox回归模型分析胃癌病人预后的影响因素。结果 胃癌组织中miR-539-5p表达水平低于癌旁组织，CAAP1表达水平高于癌旁组织，差异有统计学意义(P<0.05)。胃癌组织miR-539-5p与CAAP1表达水平存在负相关性(P=0.000)。胃癌组织miR-539-5p、CAAP1表达均与TNM分期、浸润深度、淋巴结转移、肿瘤直径显著相关(P<0.05)。miR-539-5p高表达组3年生存率高于低表达组(P=0.045)，CAAP1高表达组3年生存率低于低表达组，差异有统计学意义(P=0.015)。Cox回归显示，TNM分期、浸润深度、淋巴结转移以及miR-539-5p、CAAP1表达是胃癌病人预后影响因素(P<0.05)。结论 miR-539-5p在胃癌组织中表达水平降低、CAAP1表达水平升高，与TNM分期、浸润深度、淋巴结转移、肿瘤直径有关，且二者与病人预后密切相关。

关键词: 胃癌, 微小RNA-539-5p, Caspase活性和凋亡抑制因子1

Abstract:

Objective To investigate the expression and clinical significance of microRNA (miR)-539-5p, Caspase activity and apoptosis inhibitory factor 1 (CAAP1) in gastric cancer tissue. Methods The gastric cancer tissue specimens and corresponding adjacent tissues of gastric cancer patients (102 cases) who underwent surgery in Xi ’an Ninth Hospita from January 2018 to December 2019 were collected, and the expression levels of miR-539-5p and CAAP1 in the tissues were detected and compared. The relationship between the expression of miR-539-5p and CAAP1 and clinicopathological parameters and prognosis was explored. The correlation between miR-539-5p and CAAP1 expression was analyzed by Pearson method. Kaplan-Meier method was used to analyze the survival time of gastric cancer patients. Cox regression model was used to analyze the prognostic factors of patients with gastric cancer. Results The expression level of miR-539-5p in gastric cancer tissue lower than that in adjacent tissue, and the expression level of CAAP1 higher than that in adjacent tissue (P<0.05). There was a negative correlation between the expression levels of miR-539-5p and CAAP1 in gastric cancer tissue (P=0.000). Further analysis showed that the expression of miR-539-5p and CAAP1 in gastric cancer tissue was greatly correlated with TNM stage, depth of invasion, lymph node metastasis and tumor size (P<0.05). The 3year survival rate of miR-539-5p high expression group was higher than that of low expression group (P=0.045). The 3year survival rate of CAAP1 high expression group which was lower than low expression group (P=0.015). Cox regression showed that TNM stage, depth of invasion, lymph node metastasis and miR-539-5p and CAAP1 expression were prognostic factors in patients with gastric cancer (P<0.05). Conclusion The decreased expression level of miR-539-5p and increased expression level of CAAP1 in gastric cancer tissues were related to TNM staging, depth of invasion, lymph node metastasis and tumor size, and they are closely related to the prognosis of patients.

Key words: gastric cancer, microRNA-539-5p, Caspase activity and apoptosis inhibitory factor 1

[1] 王青峰 陆晶晶 鲁生林 汪源 吴永丰 张明府. 新辅助化疗后行腹腔镜胃癌根治术并发症有关影响因素及预后分析[J]. 临床外科杂志, 2023, 31(9): 860-863.
[2] 李一博 宋炎阳. 胃癌腹腔镜胃远端切除术不同吻合方式对并发症及胃肠功能的影响[J]. 临床外科杂志, 2023, 31(9): 865-868.
[3] 张明燃 范玥 李俊. 胃癌根治性切除消化道重建术后Petersen疝11例临床分析[J]. 临床外科杂志, 2023, 31(9): 877-880.
[4] 马立东 刘晓蕾 赵飞. 青蒿素通过TLR4/NF-κB信号通路调节胃癌细胞的生长和炎症因子分泌的机制研究[J]. 临床外科杂志, 2023, 31(8): 738-741.
[5] 刘宇 眭超 陶亮 王萌. 胃肠道术后延迟性肠麻痹研究进展[J]. 临床外科杂志, 2023, 31(7): 698-700.
[6] 徐慧 李昊 秦静静 柳涛涛 谢昌奇 张曹. 术前血浆纤维蛋白原与非转移性胃癌病人预后关系的Meta分析[J]. 临床外科杂志, 2023, 31(4): 348-352.
[7] 李斌 杨冬 周常青. 阿帕替尼联合腹腔热灌注及静脉化疗治疗晚期胃癌腹膜转移转化治疗的效果[J]. 临床外科杂志, 2023, 31(3): 256-260.
[8] 刘炯 汪向飞 江斌. 腹腔镜辅助远端胃癌根治术不同Uncut Roux-en-y吻合方式对病人的疗效及对肿瘤标志物和预后的影响[J]. 临床外科杂志, 2023, 31(2): 177-180.
[9] 张文涵 谢颂平 刘高利 龙杏林 黄杰. 食管癌术后再发上消化道恶性肿瘤的外科手术治疗[J]. 临床外科杂志, 2023, 31(12): 1141-1143.
[10] 周谦 孟宁 刘晟楠 郝向东. 胃癌组织中ARHGAP4、FBLN5的表达及与病人预后的关系[J]. 临床外科杂志, 2023, 31(11): 1057-1060.
[11] 蒋祈 张鹏 陶凯雄. 美国国立综合癌症网络临床实践指南：胃癌(2022.V2)更新解读[J]. 临床外科杂志, 2023, 31(1): 18-20.
[12] 张再重 林晨 王烈. 联合脏器切除在进展期胃癌治疗中的意义[J]. 临床外科杂志, 2022, 30(9): 813-814.
[13] 黄昌明 林国生 黄泽宁 陆俊. 吲哚菁绿标记荧光示踪技术在腹腔镜胃癌根治术中的应用[J]. 临床外科杂志, 2022, 30(9): 815-818.
[14] 周岩冰. 机器人和4K腹腔镜在胃癌根治术中淋巴结清扫的比较[J]. 临床外科杂志, 2022, 30(9): 819-822.
[15] 蔺金军 刘俊华 慕立峰 黄占有 魏军龙 李永梅. 胃癌手术、介入化疗后存活19年一例[J]. 临床外科杂志, 2022, 30(9): 828-829.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
版权所有 © 《临床外科杂志》编辑部
地址：武汉市武昌区东湖路165号　邮编：430071　电话：027-87893476　E-mail: whlcwk@126.com
本系统由北京玛格泰克科技发展有限公司设计开发
鄂ICP备11011458号-3